Lars Fruergaard Jorgensen Is the CEO Behind Ozempic and Wegovy
Novo Nordisk, the maker of weight-loss drugs like Ozempic, recently became Europe's most valuable company.
Diabetes
How Illness Affects Art: An Artist Discusses Suffering and Its Complex Relationship With Creating
While Drew Simpson’s new work is inspired by the trauma of having a dangerous illness, he definitely doesn't want to be put in that corner.
How Artificial Intelligence Is Changing the Way We Look at Food
A host of new phone-based apps and technologies are taking aim at one of the fastest growing markets in health care.
